| |
 |
|
Class Information
Number: 514/21
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Peptide containing (e.g., protein, peptones, fibrinogen, etc.) doai > Produced by or extracted from animal tissue
Description: Subject matter which is derived from animal material.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7618941 |
Treating degenerative joint disorders with tribonectins |
Nov. 17, 2009 |
| 7618648 |
Satiety inducing composition |
Nov. 17, 2009 |
| 7608284 |
Enamel matrix protein composition for treatment of systemic inflammatory response syndrome |
Oct. 27, 2009 |
| 7608283 |
Coral purification method and coral thus obtained |
Oct. 27, 2009 |
| 7601689 |
Angiogenin complexes (ANGex) and uses thereof |
Oct. 13, 2009 |
| 7601515 |
Process of high purity albumin production |
Oct. 13, 2009 |
| 7585835 |
GASP1: a follistatin domain containing protein |
Sep. 8, 2009 |
| 7582603 |
Method for treating or inhibiting intestinal inflammation |
Sep. 1, 2009 |
| 7579316 |
Compositions and methods to modulate an immune response to an immunogenic therapeutic agent |
Aug. 25, 2009 |
| 7579315 |
Casein peptides for alleviating or preventing aging of skin |
Aug. 25, 2009 |
| 7572763 |
Follistatin domain containing proteins |
Aug. 11, 2009 |
| 7572465 |
Isolated material having an anti-organotrophic effect |
Aug. 11, 2009 |
| RE40849 |
Method of treatment of glutathione deficient mammals |
Jul. 14, 2009 |
| 7531518 |
Method for fostering bone formation and preservation |
May. 12, 2009 |
| 7531509 |
Papillosin antimicrobial peptide, a gene coding said peptide, a vector, a transformed organism and a compound containing said organism |
May. 12, 2009 |
| 7531504 |
Pharmaceutical composition and method for inhibiting gastrointestinal inflammation |
May. 12, 2009 |
| 7531502 |
Diagnostic conjugate useful for intracellular imaging and for differentiating between tumor- and non-tumor cells |
May. 12, 2009 |
| 7531501 |
Method of treating endothelial injury |
May. 12, 2009 |
| 7521423 |
Exendin pharmaceutical compositions |
Apr. 21, 2009 |
| 7517530 |
Methods for treatment of insulin-like growth factor-1 (IGF-1) deficiency comprising administration of IGF-1 and growth hormone |
Apr. 14, 2009 |
| 7504115 |
Shark cartilage extracts and use thereof for immunomodulation |
Mar. 17, 2009 |
| 7476649 |
Antiproliferative and antiviral proteins and peptides |
Jan. 13, 2009 |
| 7470660 |
Treatment for dark adaptation |
Dec. 30, 2008 |
| 7470659 |
Methods to increase reverse cholesterol transport in the retinal pigment epithelium (RPE) and Bruch's membrane (BM) |
Dec. 30, 2008 |
| 7465711 |
Treatment of cancers of lymphocytic cells with product R |
Dec. 16, 2008 |
| 7452867 |
Use of ADNF polypeptides for treating peripheral neurotoxicity |
Nov. 18, 2008 |
| 7445764 |
Carrier-drug conjugate |
Nov. 4, 2008 |
| 7442308 |
Process for removing viruses in fibrinogen solutions and fibrinogen obtained by said process |
Oct. 28, 2008 |
| 7439234 |
Method for treating cancer patients undergoing chemotherapy |
Oct. 21, 2008 |
| 7432241 |
Device for treating diabetes and methods thereof |
Oct. 7, 2008 |
| 7429567 |
Sustained delivery of PDGF using self-assembling peptide nanofibers |
Sep. 30, 2008 |
| 7425542 |
Stabilizing alkylglycoside compositions and methods thereof |
Sep. 16, 2008 |
| 7419683 |
Method of inhibiting side effects of pharmaceutical compositions containing amphiphilic vehicles or drug carrier molecules |
Sep. 2, 2008 |
| 7417023 |
Targeted delivery of bioaffecting compounds for the treatment of cancer |
Aug. 26, 2008 |
| 7407934 |
Methods for regulating postprandial blood glucose |
Aug. 5, 2008 |
| 7393829 |
Pharmaceutical compositions comprising fragments and homologs of troponin subunits |
Jul. 1, 2008 |
| 7388124 |
Non-traumatic model for neurogenic pain |
Jun. 17, 2008 |
| 7384918 |
Botulinum toxin for treating muscle contracture |
Jun. 10, 2008 |
| 7384916 |
Methods and compositions for preventing and treating aging or photodamaged skin |
Jun. 10, 2008 |
| 7378389 |
Botulinum toxin neurotoxic component for treating juvenile cerebral palsy |
May. 27, 2008 |
| 7378096 |
Stress protein compositions and methods for prevention and treatment of cancer and infectious disease |
May. 27, 2008 |
| 7375080 |
Immobilized lactoferrin (Im-LF) antimicrobial agents and uses thereof |
May. 20, 2008 |
| 7371721 |
Use of GLP-2 and related compounds for the treatment, prevention, diagnosis, and prognosis of bone-related disorders and calcium homeostasis related syndromes |
May. 13, 2008 |
| 7371411 |
Methods for production of the oxidized glutathione composite with CIS-diamminedichloroplatinum and pharmaceutical compositions based thereof regulating metabolism, proliferation, differentiati |
May. 13, 2008 |
| 7368425 |
Cyclic peptides for modulating growth of neo-vessels and their use in therapeutic angiogenesis |
May. 6, 2008 |
| 7358284 |
Particulate acellular tissue matrix |
Apr. 15, 2008 |
| 7354896 |
Administration of leptin |
Apr. 8, 2008 |
| 7351693 |
Peptides and nucleic acids of the cathelicidin family, derived from fish, and uses thereof |
Apr. 1, 2008 |
| 7351422 |
Hemostatic soluble cellulose fibers containing coagulating protein for treating wound and process for producing the same |
Apr. 1, 2008 |
| 7344699 |
Drug conjugate comprising an erythropoietin receptor ligand and an anticancer agent |
Mar. 18, 2008 |
|
|
|
